tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Adaptive Biotechnologies: Sustained MRD Growth, Pricing Power, and Strategic Positioning Support Buy Rating and Premium Valuation
PremiumRatingsAdaptive Biotechnologies: Sustained MRD Growth, Pricing Power, and Strategic Positioning Support Buy Rating and Premium Valuation
10d ago
Adaptive Biotechnologies: Strong MRD Momentum, Enhanced 2026 Outlook, and Clear Path to Profitability Support Buy Rating
Premium
Ratings
Adaptive Biotechnologies: Strong MRD Momentum, Enhanced 2026 Outlook, and Clear Path to Profitability Support Buy Rating
10d ago
Adaptive Biotechnologies reports Q4 EPS (9c), consensus (18c)
Premium
The Fly
Adaptive Biotechnologies reports Q4 EPS (9c), consensus (18c)
11d ago
Adaptive Biotechnologies Reports Strong Preliminary Q4 2025 Growth
PremiumCompany AnnouncementsAdaptive Biotechnologies Reports Strong Preliminary Q4 2025 Growth
1M ago
Adaptive Biotechnologies sees Q4 revenue $72M, consensus $59.38M
Premium
The Fly
Adaptive Biotechnologies sees Q4 revenue $72M, consensus $59.38M
1M ago
Adaptive Biotechnologies price target raised to $20 from $19 at TD Cowen
Premium
The Fly
Adaptive Biotechnologies price target raised to $20 from $19 at TD Cowen
1M ago
Cathie Wood Doubles Down on Bitcoin, Cuts Exposure Across Tech and Genomics
PremiumMarket NewsCathie Wood Doubles Down on Bitcoin, Cuts Exposure Across Tech and Genomics
2M ago
Adaptive Biotechnologies announces growing interventional use of clonoSEQ test
Premium
The Fly
Adaptive Biotechnologies announces growing interventional use of clonoSEQ test
2M ago
Buy Rating for Adaptive Biotechnologies: Strong Market Position and Strategic Growth Initiatives
Premium
Ratings
Buy Rating for Adaptive Biotechnologies: Strong Market Position and Strategic Growth Initiatives
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100